Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2015 ∙ Malerba, V. Costantino, C. Napoli, G. Marchese, V. Casuccio, A. Tabacchi, G. Vitale, F.

Antimeningococcal and antipneumococcal vaccination determinants: a European systematic literature review

  • Europe
  • Adolescents
  • Adults
  • Older adults
  • Parents/caregivers
  • Meningococcal disease
  • Pneumococcal disease
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2015 ∙ Vlachopoulos, C. V. Terentes-Printzios, D. G. Aznaouridis, K. A. Pietri, P. G. Stefanadis, C. I.

Association between pneumococcal vaccination and cardiovascular outcomes: A systematic review and meta-analysis of cohort studies

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Wu, D. B. C. Chaiyakunapruk, N. Chong, H. Y. Beutels, P.

Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006-2014)

  • All age groups
  • Pneumococcal disease
  • Economic aspects
  • Administration
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2015 ∙ Caya, C. A. Boikos, C. Desai, S. Quach, C.

Dosing regimen of the 23-valent pneumococcal vaccination: A systematic review

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Ren, S. Newby, D. Li, S. C. Walkom, E. Miller, P. Hure, A. Attia, J.

Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ De Waure, Chiara Specchia, Maria Lucia Capizzi, Silvio Aljicevic, Mufida Dujovic, Milos Malaj, Admir Ricciardi, Walter

Effectiveness of 7-valent pneumococcal conjugate vaccine: A meta-analysis of post-marketing studies

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Bonner, K. Welch, E. Elder, K. Cohn, J.

Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Chaithongwongwatthana, S. Yamasmit, W. Limpongsanurak, S. Lumbiganon, P. Tolosa, J. E.

Pneumococcal vaccination during pregnancy for preventing infant infection

  • Pregnant women
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2015 ∙ Alqahtani, A. S. Rashid, H. Heywood, A. E.

Vaccinations against respiratory tract infections at Hajj

  • All age groups
  • Influenza
  • Pneumococcal disease
  • Diphtheria
  • Tuberculosis
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2015 ∙ Johansen, H. K. Gotzsche, P. C.

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
Loading...